GGrantIndex
← Search

AN INTEGRATED OMICS APPROACH FOR TREATMENT OF STEROID-RESISTANT NEPHROTIC SYNDROME IN PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS

$4,759,050FY2019Department of the ArmyDOD

Angion Biomedica Corp.

Investigators

View source on USAspending →
AN INTEGRATED OMICS APPROACH FOR TREATMENT OF STEROID-RESISTANT NEPHROTIC SYNDROME IN PRIMARY FOCAL SEGMENTAL GLOMERULOSCLEROSIS · GrantIndex